| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| E. Ohman J:or Asset Management AB | 9 | 9 | 0.02% | 0.04% | 0.06% | Q4 2006 | Q4 2008 | 9 |
| GOLDMAN SACHS GROUP INC | 2 | 2 | 0.00% | 0.01% | 0.04% | Q1 2012 | Q2 2012 | 6 |
| HUNTINGTON NATIONAL BANK | 5 | 5 | 0.00% | 0.00% | 0.00% | Q3 2010 | Q3 2011 | 5 |
| MUFG Americas Holdings Corp | 5 | 5 | 0.00% | 0.00% | 0.01% | Q4 2010 | Q4 2011 | 5 |
| BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp | 4 | 4 | 0.00% | 0.00% | 0.01% | Q3 2011 | Q2 2012 | 4 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3 | 3 | 0.03% | 0.04% | 0.04% | Q4 2011 | Q2 2012 | 3 |
| NORGES BANK | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2012 | Q2 2012 | 1 |
| Bank of New York Mellon Corp | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2011 | Q1 2011 | 1 |
External links
This page lists all the filers that currently own AMYLIN PHARMACEUTICALS INC or have owned AMYLIN PHARMACEUTICALS INC in the past.